CVS Health (CVS) shares tumbled on Nov. 4 after the healthcare giant announced plans to split its business into two independent publicly traded companies. CVS will separate its retail pharmacy business from its insurance, pharmacy-benefit management, and healthcare-services operations, with the restructuring expected to be completed in the first half of 2028.
Including today’s decline, CVS stock is trading nearly 30% below its year-to-date high in late July.